Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
Manchester United unveils a £50 million redevelopment of its Carrington Training Complex, aiming to restore the club's competitive edge with state-of-the-art facilities and a focus on player wellbeing.
Ravens and Colts lose rookie cornerbacks for the season due to torn ACLs and MCLs, a significant setback for their secondary depth.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
Manchester United unveils a £50 million redevelopment of its Carrington Training Complex, aiming to restore the club's competitive edge with state-of-the-art facilities and a focus on player wellbeing.
Ravens and Colts lose rookie cornerbacks for the season due to torn ACLs and MCLs, a significant setback for their secondary depth.